#AskBQ: Nirma To Acquire 75% In Glenmark Life Sciences

The pharma company will sell a 75% stake in Glenmark Life Sciences at Rs 615 apiece, lowering the stake to 7.84% after the sale.

Glenmark Pharma Shares Fall As It Plans To Sell Life Sciences Business

Here are the top 10 stocks you need to keep on your radar in today's trading session. Take a look.

#topstocksinfocus #buzzingstocks #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here

Key Stocks In Focus: Glenmark Life Sciences, Wipro, IdeaForge Tech, ICCI Lombard, ICCI Securities

Nirma will make the mandatory open offer to all public shareholders of Glenmark Life Sciences.

Glenmark Agrees To Sell 75% In Life Sciences Unit To Nirma For Rs 5,652 Crore

Glenmark Pharma divests 75% stake in Glenmark Life Sciences to Nirma for Rs 5,651 crore.

CMD Glenn Saldanha addresses the media. #BQLive

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Glenmark Pharma To Sell 75% Stake In Glenmark Life | BQ Prime

Private equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma’s stake in Glenmark Life Sciences (GLS) with rival bidder Nirma. Along with Nirma and ChrysCapital, Sekhmet Pharmaventures backed by PE firms PAG, CX Partners and Samara Capital also in the list of potential invest…

ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences

The management of Glenmark Pharmaceuticals is looking to divest about 8 per cent stake in Glenmark Life Sciences

Glenmark Pharma looking to divest 8 per cent in Glenmark Life Sciences

Glenmark Life Sciences Hits Target: What’s Next? Zomato’s Bullish Journey Explored

India’s Nirma, known for its washing detergent, is seeking to expand into the pharma sector by becoming the leading contender to buy Glenmark Life Sciences. If successful, it will be Nirma’s largest acquisition since buying LafargeHolcim’s Indian cement assets for $1.4bn in 2016.

The little girl twirls on: Nirma’s journey from washing powder to cement to pharma

Nirma Group is likely to acquire an 82.84% stake in Glenmark Life Sciences in a deal worth INR 6,664 to INR 7,000 crore. The company has emerged as the sole bidder following the deadline last week, with the acquisition likely to be facilitated by healthcare subsidiary Aculife Healthcare.

Nirma closes in on Glenmark’s API arm, emerges sole contender as bid deadline ends

Nirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-listed company held by Glenmark Pharmaceuticals Ltd which has a portfolio of 139 molecules and supplies its products to customers in India and abroad including Europ…

Washing powder maker Nirma and Sekhmet vie for $731 million Glenmark Life stake: Sources

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Glenmark Life Sciences Ltd is a manufacturer of pharmaceutical preparation. The Company was founded in June 2011 and is located in Solapur, India.